Background: Sequencing studies across multiple cancers continue to reveal the spectrum of mutations and genes involved in the pathobiology of these cancers. Exome sequencing of oral cancers, a subset of Head and Neck Squamous cell Carcinomas (HNSCs) common among tobacco-chewing populations, revealed that ~34% of the affected patients harbor mutations in the CASP8 gene. Uterine Corpus Endometrial Carcinoma (UCEC) is another cancer type where about 10% cases harbor CASP8 mutations. Caspase-8, the protease encoded by CASP8 gene, plays a dual role in programmed cell death, which in turn has an important role in tumor cell death and drug resistance. CASP8 is a protease required for the extrinsic pathway of apoptosis and is also a negative regulator of necroptosis. Using bioinformatics approaches to mine data in The Cancer Genome Atlas, we compared the molecular features and survival of these carcinomas with and without CASP8 mutations.
Background
Exome sequencing, RNA-sequencing, and copy number variation analysis of different cancers have revealed a cornucopia of disease-relevant mutations and altered pathways. The identified genes included those with broad relevance across different cancers, as well as genes that were relevant only in one or a few cancer types. Arguably, the next phase will involve parsing this voluminous data to generate ideas and hypotheses with the potential for clinical impact, and then testing them experimentally.
We are particularly interested in the heterogeneous group of Head and Neck Squamous cell Carcinomas (HNSCs) as these account for a large number of mortalities each year in the Indian subcontinent. Multiple exome sequencing studies have revealed the landscape of recurrent somatic mutations in HNSCs and its prevalent subtype of Oral Squamous Cell Carcinomas (OSCCs) [1] [2] [3] [4] [5] . While TP53 was the most significant recurrently mutated gene in this cancer type, several other genes such as CASP8, FAT1, and NOTCH1 were also unearthed as significantly recurrently mutated by these large-scale sequencing studies. The precise roles of these genes in oral epithelium homeostasis, and how this is altered owing to their mutation in cancer remain to be fully elucidated [6] . In this study, we chose to focus on the CASP8 gene, which is mutated in 34% of cases with OSCC of the gingiva-buccal sulcus (OSCC-GB), and in ~10% of HNSC patients [1, 2, 4] .
Interestingly, in addition to HNSC, CASP8 is also recurrently mutated in about 10% of Uterine Corpus Endometrial Carcinoma (UCEC) cases. Here again, the role of CASP8 in endometrial tissue homeostasis, and how this is altered owing to its mutation in UCEC remains unclear.
CASP8 is also mutated in other cancer types, however, the numbers of such tumors are too low for meaningful analyses. Thus, using the sequencing data on ~500 head and neck and uterine corpus endometrial carcinoma tumors available in The Cancer Genome Atlas (TCGA) [7, 8] , we sought to identify distinctive features of mutant-CASP8 tumors.
CASP8 regulates two pathways of programmed cell death; it is a key protease required for the initiation of the extrinsic apoptotic pathway that is targeted by some drug-resistant tumors, and it is an important negative regulator of necroptosis [9] [10] [11] [12] . Loss-of-function mutations in CASP8 could lead to reduced apoptosis and promote tumor survival. It could also lead to enhanced necroptosis and promote tumor cell death. Interestingly, it has been proposed that the necroptotic pathway could be utilized to develop anti-cancer treatments for countering cancers with resistance to apoptosis [13] . On the background of these observations, tumors harboring CASP8 mutations offer a tractable, physiologically relevant opportunity to understand the changes brought about by CASP8 mutation, how it affects survival, and if CASP8 or the necroptotic pathway could be a potential drug target.
In this study, we describe the comparison of RNA-sequencing (RNA-seq) data from head and neck squamous cell carcinoma, and later from uterine corpus endometrial carcinoma, that are mutant or wild type for CASP8. We report distinctive molecular features of mutant-CASP8 HNSCs and UCECs that this comparison revealed. In addition, we describe results obtained by correlating these features to overall survival in the affected patients.
Methods

Differential Gene Expression Analysis of wild-type-CASP8 and mutant-CASP8 cases
Data for 528 head and neck squamous cell carcinoma (HNSC) cases available at The Cancer Genome Atlas (TCGA) were downloaded in May-June 2017 from https://portal.gdc.cancer.gov/.
Clinical data files, Mutation Annotation Format (MAF) files, and mRNA quantification files such as HTSeq files (files with number of reads aligning to each protein-coding gene) and FPKM-UQ files (files with number of fragments aligning per kilobase of transcript per million mapped reads normalized to upper quartile) were downloaded. The HPV status of HNSC cases at TCGA has been reported earlier [14] , and this data was used to assign HPV-positive and HPV-negative cases. Cases with and without CASP8 mutation were selected as shown in figure 1. Among selected cases, mRNA quantification data was available for 354 cases with wild-type-CASP8
(CASP8-WT) and 53 cases with mutant-CASP8 (CASP8-MT). Raw reads from HTSeq files for these cases were used for edgeR analysis [15] , to identify genes that were differentially expressed between CASP8-WT and CASP8-MT.
Data for 560 uterine corpus endometrial carcinoma (UCEC) cases available at TCGA were downloaded in February 2018. CASP8 mutations of high or moderate impact were present in 56 UCEC cases. mRNA quantification data was available for 476 CASP8-WT tumors and 56
CASP8-MT tumors. Raw reads from HTSeq files from these cases were used for edgeR analysis to identify differentially expressed genes. 1231 genes were found to be differentially regulated at FDR<0.001. Of these, 596 genes were downregulated with logFC<1.3 and 258 genes were upregulated with logFC>1.3.
Gene Ontology and Gene Set Enrichment Analysis (GSEA)
Enrichment analysis to identify biological processes overrepresented among genes differentially expressed between CASP8-WT and CASP8-MT HNSCs was performed at http://geneontology.org/ [16] . GSEA was performed using a pre-ranked gene list and hallmark gene sets available at the Molecular Signature Database [17] . The hallmark gene sets use either HGNC or entrez gene ids as the gene identifier. Out of the 60,483 transcripts analyzed by edgeR, HGNC gene symbols could be assigned to 37,095. logFC values for these 37,095 genes from the edgeR output from HNSC and UCEC differential gene expression analyses were used to generate the pre-ranked gene list. To perform GSEA with genes that were up-regulated in the skin of mice lacking functional Caspase-8, the top 100 up-regulated genes were selected [18] . Of these 100 genes, 80 genes had corresponding human orthologs (CASP8-KOSET) as identified using tools available at http://www.informatics.jax.org/. GSEA was then performed using the pre-ranked gene list and the CASP8-KOSET.
Immune Cell Infiltration in HNSC and UCEC cases
Data for distribution of immune infiltrates in TCGA cases was downloaded from Tumor IMmune Estimation Resource (TIMER) at https://cistrome.shinyapps.io/timer/ [19] . Data was available for 353 CASP8-WT and 51 CASP8-MT cases from HNSC. The comparison of immune cell infiltration levels across CASP8-WT, CASP8-MT, and HPV-positive cases was performed using a two-sided Wilcoxon rank test and the graphs were plotted using R. Similar analysis was performed for all CASP8-MT and CASP8-WT cases from UCEC.
Survival Analysis
Survival analysis was performed to investigate the difference in the survival of CASP8-WT and CASP8-MT patients from HNSC and UCEC. Survival analysis was also performed to investigate the effect of factors such as expression levels of certain genes and immune cell infiltration on survival. The expression levels of genes of interest were obtained from FPKM-UQ files from TCGA and the data for distribution of immune cell infiltration was obtained from TIMER. Kaplan-Meier curves for CASP8-WT and CASP8-MT cases were plotted using the Survival and Survminer packages in R and the plots were compared using the log-rank test [20] .
To investigate the effect of genes of interest (such as those from gene sets enriched in GSEA or genes involved in necroptosis) and immune cell infiltration levels on survival, multivariate Cox proportional hazards test was performed for HNSC cases. In addition, Cutoff Finder tool available at http://molpath.charite.de/cutoff/ was used to investigate the influence of a single continuous variable on survival [21] . In this analysis of either CASP8-WT or CASP8-MT cases, the data for each variable was stratified into two groups at the point with the most significant logrank test.
Results
Genes involved in immune response are up-regulated in mutant-CASP8 HNSCs
To investigate the significance of CASP8 mutations in head and neck squamous cell carcinoma (HNSC), we performed differential gene expression analysis using RNA-seq data from HNSC cases with and without CASP8 mutations, as described in figure 1 . CASP8 mutations were identified using the Mutation Annotation Format (MAF) files. The workflow for somatic mutation calling at TCGA uses four different pipelines: SomaticSniper, MuSE, MuTect2, and VarScan2.
Mutation(s) in the CASP8 gene identified by any one of these four pipelines was included in this study. Using this criterion, CASP8 mutations were identified in 55 HNSC cases. Notably, the majority (80%) of the identified CASP8 mutations were predicted by more than one program, and all had either high or moderate impact on function.
As reported previously, HNSCs carrying CASP8 mutations occurred predominantly in sites within the oral cavity such as the cheek mucosa, floor of mouth, tongue, larynx, and overlapping sites of the lip, oral cavity, and pharynx (Supplementary Table 1 ). In addition, since HPVpositive (Human Papillomavirus-positive) HNSCs constitute a molecularly distinct subtype; we examined the HPV status of the 55 mutant-CASP8 HNSCs using data from Chakravarthy et al [14] . Based on this reported data, all 55 mutant-CASP8 HNSCs were found to be HPV-negative.
Since all the HNSC cases carrying CASP8 mutations were HPV-negative, and were from specific sites within the oral cavity, HNSCs carrying wild-type-CASP8 that were HPV-negative and also from these same sites were selected as controls for all subsequent analyses. A total of 424 HNSC cases of which 369 had wild-type-CASP8 (CASP8-WT) and 55 had mutant-CASP8 (CASP8-MT) were thus selected ( Figure 1 , see also Supplementary Table 1 ). Of these, RNAseq data was available for 354 CASP8-WT and 53 CASP8-MT cases.
HTSeq files containing raw sequencing reads from CASP8-WT and CASP8-MT cases were subjected to edgeR analysis for differential gene expression (Supplementary Table 2 ). At Table 3 ).
We further analyzed the differential gene expression data using the Gene Set Enrichment Analysis (GSEA) tool. After generating a pre-ranked gene list based on logFC values from the edgeR analysis, we queried this list in the GSEA software using hallmark gene sets available at the Molecular Signatures Database. Several gene sets involved in immune regulation such as allograft rejection, complement, inflammatory response, interferon-α response, and interferon-γ response, were specifically enriched in the CASP8-MT HNSCs, in sync with the GO results ( Figure 2B and Supplementary Table 4 ). The hallmark gene sets enriched in CASP8-WT HNSCs were epithelial-mesenchymal transition (EMT), myogenesis, and the KRAS pathway ( Figure 2B and Supplementary Table 4 ).
Gene expression in the skins of epidermal Caspase-8 knockout mice mirrors the expression pattern of mutant-CASP8 HNSCs
Expression of an enzymatically inactive Caspase-8 mutant or the deletion of wild-type Caspase-8 in the mouse epidermis leads to chronic skin inflammation [18, 22] . Table 5 ), we again queried the pre-ranked gene list with the GSEA tool. As seen in figure 2C , genes highly expressed in the Casp-8 F/-K5-Cre mouse skins were also significantly enriched in CASP8-MT HNSCs (as opposed to their wild-type counterparts), indicating that the inactivation of CASP8 leads to the up-regulation of a similar set of genes in both mouse and human epidermal tissues.
Enrichment of immune response gene sets correlates with increased infiltration of specific immune cell types in mutant-CASP8 HNSCs
Since genes involved in the immune response were specifically enriched in CASP8-MT HNSCs, we investigated if this enrichment correlated with the presence or infiltration of immune cells in these tumors. Using the data available at Tumor IMmune Estimation Resource (TIMER) [19] , a comprehensive resource for immune cell infiltration of TCGA tumors, we checked if there was a 1 0 difference in the numbers/types of tumor-associated immune cells between the CASP8-WT and CASP8-MT HNSCs. Consistent with the GSEA results, CASP8-MT cases showed significantly higher infiltration of CD8 + T cells, neutrophils, and dendritic cells as compared to CASP8-WT cases (p-values<0.0005), suggesting that the immune response to the tumor in WT and MT cases was different ( Figure 3A ). It has been widely reported that HPV-positive HNSCs have higher infiltration of immune cells as compared to HPV-negative HNSCs [23, 24] . In agreement with these reports, HPV-positive HNSCs had significantly higher infiltration of CD8 + T cells, neutrophils, and dendritic cells as compared to the CASP8-WT HNSCs, but not when compared to the CASP8-MT HNSCs ( Figure 3A) . However, HPV-positive HNSCs also had high levels of infiltration of CD4 + T cells and B cells which was not observed in either CASP8-WT or CASP8-MT HNSCs ( Figure 3B ). Table 6 ). We also performed the survival analysis using Cutoff Finder to investigate the effect of the expression of individual genes on the survival of CASP8-WT and CASP8-MT cases. Increased expression of all the four genes was significantly associated with higher overall survival in CASP8-WT but less so in CASP8-MT cases ( Figure 4B and Supplementary Figure 1) . Similarly, higher CD8 + T cell estimates (from TIMER) was also significantly associated with better survival in CASP8-WT but not in CASP8-MT HNSCs ( Figure   4B ). Since CASP8 is a negative regulator of the necroptotic pathway [11, 12] , we also investigated the effect of expression levels of genes involved in necroptosis on survival. Higher expression of RIPK1, RIPK3, and MLKL was associated with higher overall survival in CASP8-WT but not in CASP8-MT cases ( Supplementary Figure 2 ). Additional factors that influenced survival are shown in supplementary table 6.
Mutant-CASP8 UCECs exhibit an immune signature similar to mutant-CASP8 HNSCs
We then investigated if this effect seen in CASP8-MT HNSCs was broadly applicable across other cancers carrying CASP8 mutations. Apart from HNSC, among the cancers covered by the TCGA program, UCECs carried the most numbers of mutations in the CASP8 gene. About ~10% UCECs harbor CASP8 mutations. From a total of 560 UCEC cases, RNA-seq data was available for 476 CASP8-WT and 56 CASP8-MT cases. HTSeq files containing raw sequencing reads from these two groups were subjected to edgeR analysis for differential gene expression and further analyzed using the GSEA tool. Several gene sets involved in immune regulation were specifically enriched in the CASP8-MT UCECs. Notably, categories such as allograft rejection, interferon-α response, and interferon-γ response, were enriched in the CASP8-MT UCECs similar to the HNSC results. However, unlike HNSCs, the gene set for inflammatory response did not show any enrichment in CASP8-MT UCECs. CASP8-MT UCECs were additionally enriched for genes involved in apoptosis. Notably, this was not observed in the CASP8-MT HNSCs ( Figure 5A , see also figure 2B ).
High levels of IL33 and neutrophil infiltration are observed in mutant-CASP8 HNSCs but not in mutant-CASP8 UCECs
Using TIMER, we then checked the levels of infiltrating immune cells in the CASP8-WT and CASP8-MT UCECs. Consistent with the GSEA results, CASP8-MT UCEC cases showed significantly higher infiltration of CD8 + T cells and dendritic cells as compared to CASP8-WT cases (p-values<0.005). However, in contrast to the HNSC data, the levels of neutrophils were not significantly higher in the CASP8-MT UCEC group ( Figure 5B , see also figure 3A ). We then investigated if differences in the levels of neutrophil-active chemokines could potentially explain this observation [25] . From the edgeR differential expression data comparing the CASP8-MT and CASP8-WT groups in HNSC and UCEC, we obtained the fold change values and statistical significance of different chemokines known to attract neutrophils ( Supplementary table 7) .
Interestingly, the cytokine IL33 was significantly up regulated (1.8 fold, FDR<0.001) in CASP8-MT HNSCs but not in CASP8-MT UCECs.
Discussion
Here, we report a distinct class of carcinomas that have mutated CASP8. Using bioinformatics approaches to mine the TCGA data, we identified immune response-related genes as a prominent shared category of genes enriched in CASP8-MT carcinomas. We then explored the correlation of this gene set enrichment with survival. Our analyses showed that despite similarities in the enrichment of gene sets, these carcinomas exhibited varying correlations of immune signature with survival. In the first part of our analyses, we investigated the implications of the enrichment of this immune signature across different HNSC subtypes. Subsequently, in the second part, we investigated the correlation between immune signature and survival in two carcinomas having a significant number of cases with CASP8 mutations, HNSC and UCEC. Our studies indicated that tissue-specific differences, such as the levels of infiltrating neutrophils and the cytokine IL33, could be responsible for the varying correlation of immune signature with survival.
Multiple studies have reported that HPV-positive HNSCs display a strong immune signature and high infiltration of immune cells that correlates with better survival. In contrast, our studies show that the enrichment of immune response genes and infiltration of immune cells in CASP8-MT HNSCs does not correlate with improved prognosis. In fact, CASP8 mutation leads to the loss of a survival advantage that is observed in HNSC patients with wild-type CASP8 tumors under certain conditions. These results argue that a tumor microenvironment with high infiltration of immune cells does not necessarily provide a survival benefit in HNSCs.
We can think of at least two potential scenarios to explain the increased immune cell infiltration observed in CASP8-MT tumors. (a) Unregulated inflammatory and wound healing response: As mentioned earlier, loss of Caspase-8 in the mouse epidermis leads to chronic inflammation [18] .
The infiltration of immune cells in mucosa lacking CASP8 accompanied by the enrichment of immune-associated gene sets is highly reminiscent of this phenotype. It has also been proposed that the loss of Caspase-8 in the mouse skin epidermis simulates a wound healing response [22] . Both scenarios involve a gamut of immune cell types and secreted cytokine factors, leading to immune cell infiltration. It should however be noted that although similar gene sets are enriched in mouse skins lacking Caspase-8 and in CASP8-MT tumors, the types of immune cell infiltrates in the two are different. (b) Necroptosis: More recently, several studies have revealed a role for Caspase-8 as an inhibitor of necroptosis, a highly pro-inflammatory mode of cell death [9, 10] . In intestinal epithelia, the loss of Caspase-8 promoted necroptosis through the activation of RIP kinases and MLKL [11, 12] . A similar scenario could be occurring in CASP8-MT tumors leading to the expression of pro-inflammatory genes and the infiltration of immune cells (see model in figure 6 ).
Why doesn't the increased number of immune cells translate into improved prognosis in
CASP8-MT HNSC tumors? Since CASP8 is an important mediator of the extrinsic apoptotic pathway, CASP8-MT tumors may have greater resistance to Fas-or DR5-mediated cell death pathways, which are typically employed by CD8 + T cells and Natural Killer cells to target infected/tumor cells [26, 27] . The survival analysis carried out in this study showed that CASP8-WT HNSC patients with higher expression of genes involved in T-cell mediated cytotoxicity had better survival. Importantly, this advantage was not seen in CASP8-MT patients.
Several studies have reported that high neutrophil numbers and an elevated neutrophil/lymphocyte ratio portended poorer prognosis in OSCC [28, 29] . Thus, it is possible that elevated levels of neutrophil infiltration seen in CASP8-MT HNSC cases could be one of perhaps several events contributing to the poorer prognosis of CASP8-MT HNSCs (see model in figure 6 ). IL33, a cytokine and an alarmin linked to necroptosis may represent a possible mechanism for neutrophil recruitment in these cases [30, 31] . High IL33 levels are also associated with poor prognosis in HNSCs [32] . In addition, the pro-inflammatory environment generated during necroptosis may hold other advantages for the survival of CASP8-MT HNSCs.
Necroptosis, IL33 levels, and neutrophil infiltration together or through independent mechanisms could be leading to a pro-tumor environment. Thus, promoting necroptosis may not necessarily translate into better survival for HNSC patients with apoptosis-resistant tumors.
Another reason for the lack of survival advantage in CASP8-MT HNSCs could be the composition of tumor-infiltrating immune cells in these tumors. For instance, HPV-positive tumors had higher levels of B cells and CD4 + T cells as compared to CASP8-MT tumors. It is likely that in addition to cytotoxic T cells, B cells and CD4 + T cells are required to mediate an immune response essential for tumor cell death, possibly for tumor antigen presentation or cytokine secretion.
A comparison of CASP8-MT HNSCs and CASP8-MT UCECs highlighted important differences between the two carcinomas. Notably, CASP8-MT UCECs showed a significant survival advantage over CASP8-WT UCECs, unlike its HNSC counterpart. While we do not yet know the causal reason(s), the differences per se may be worth noting and could be responsible for this advantage. For instance, in contrast to CASP8-MT HNSCs, the gene set for inflammatory response was not enriched but the gene set for apoptosis was enriched in CASP8-MT UCECs.
There was also no increased infiltration of neutrophils or transcriptional upregulation of IL33 in CASP8-MT UCECs. The up-regulation of apoptotic pathways together with the lack of enrichment of an inflammation-associated gene set that is typical of necroptosis perhaps indicates that apoptosis, rather than necroptosis, is the predominant mode of programmed cell death in CASP8-MT UCECs. This lack of inflammation may also be responsible for the lack of neutrophil infiltration in CASP8-MT UCECs since neutrophil chemoattractants, such as IL33, may not be released during apoptosis but is perhaps released during the highly inflammatory process of necroptosis, in turn leading to neutrophil infiltration.
It is also possible that necroptosis is initiated in CASP8-MT UCECs but the accompanying IL33 up-regulation and/or neutrophil infiltration seen in HNSCs does not take place due to tissuespecific differences. Under such conditions, apoptosis and necroptosis together could provide the survival advantage that is observed in CASP8-MT UCECs. Thus, in contrast to HNSCs, Caspase-8 pathway can be explored to identify potential drug targets in UCECs.
Conclusions
In this in silico study, we explore the functional implications of CASP8 mutations that have been identified across carcinomas through large-scale genomic studies. Our studies show that HNSC cases with CASP8 mutation were identified using MAF files from TCGA. Tumors with CASP8 mutation occurred in specific sub sites in oral cavity and were HPV-negative. Therefore, HPV-negative HNSC cases with wild-type-CASP8 and the same sub sites were used as control.
Gene expression data from HTSeq files of selected cases with CASP8 mutation and corresponding wild-type control cases was analyzed using edgeR to identify genes that were differentially expressed in CASP8-WT or CASP8-MT HNSCs. DEGs: Differentially Expressed Genes, FDR: False Discovery Rate. Significance testing was performed using the unpaired two-sided Wilcoxon test. All comparisons with P-value<0.005 were considered significant and are indicated in the plots. Boxplots showing the levels of CD8 + T cells and dendritic cells in the two UCEC groupsare displayed. Significance testing was performed using the unpaired two-sided Wilcoxon test. All comparisons with P-value<0.005 were considered significant and are indicated in the plots. C.
Kaplan-Meier plots showing the survival probability of patients with CASP8-WT or CASP8-MT UCEC tumors. Log-rank test was used to compare the two curves and the log-rank P-value is indicated. Tumors with mutation in CASP8 are protected from apoptosis and such patients lose the survival advantage associated with T cell activation and high expression of apoptosis-related genes. CASP8 mutation also promotes necroptosis that leads to further inflammation, production of alarmins such as IL33, and infiltration of certain immune cells including neutrophils that are known to promote invasion in OSCC. However, unlike other pro-inflammatory situations such as in HPV-positive tumors, the particular inflammatory microenvironment created due to CASP8 mutation does not appear to provide survival advantage to the patients. 
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